Pharmacogenomic Testing Cost: What You’ll Pay in 2026

Pharmacogenomic testing prices range from $19 to over $2,000 depending on the type of test, who orders it, and whether you already have DNA data. This guide breaks down the actual costs for every major option available in 2026, from clinical tests like GeneSight to affordable alternatives that use your existing 23andMe or AncestryDNA raw data.

Quick Cost Overview

Here is the pricing landscape at a glance:

• Clinical PGx testing (GeneSight, Genomind, OneOme): $250 to $2,000+ out of pocket, depending on insurance coverage
• GeneSight self-pay: $330 (their published out-of-pocket maximum)
• Raw DNA data reuse (DecodeMyBio): $19 to $59 per report, using data you already have
• Insurance coverage: Possible for clinical tests (especially Medicare); not applicable to raw DNA reuse services

The cost difference between clinical testing and raw DNA reuse is significant enough that it is worth understanding exactly what each option includes and where the value lies.

Clinical Pharmacogenomic Testing Costs

Clinical pharmacogenomic tests are ordered by a healthcare provider, performed in a CLIA-certified lab, and produce results intended for direct clinical use. Here are the major players and their pricing:

GeneSight

GeneSight is the most widely known clinical PGx test, focused primarily on psychiatric medications. Their published out-of-pocket maximum is $330 for patients who do not have insurance coverage or whose insurance denies the claim. With insurance, the patient responsibility varies — some pay nothing, others pay a copay, and some see bills for $500+ before GeneSight's financial assistance kicks in. See our detailed GeneSight cost and insurance breakdown.

Genomind

Genomind's Professional PGx Express test covers 24 genes and is also focused on mental health medications. Pricing is similar to GeneSight, typically $300 to $500 out of pocket. They offer a financial assistance program. Read our GeneSight vs. Genomind comparison for a detailed breakdown.

OneOme (RightMed)

OneOme's RightMed test is broader, covering medications across psychiatry, cardiology, pain, and oncology. Pricing is similar — $300 to $600 out of pocket, with insurance potentially covering part of the cost.

Hospital and health-system testing

Some academic medical centers and integrated health systems offer PGx testing as part of clinical care. Costs vary widely — from $200 at a research-oriented center to $2,000+ at facilities that use external reference labs. Hospital-based testing often has the best insurance coverage but the worst price transparency.

Does Insurance Cover PGx Testing?

Insurance coverage for pharmacogenomic testing is inconsistent and evolving. Here is the current state:

Medicare Part B

Medicare Part B covers GeneSight and some other PGx tests when ordered by a treating physician for patients who are being prescribed or considering psychiatric medications. This is one of the most reliable coverage pathways. If you are a Medicare beneficiary, clinical PGx testing may cost you nothing out of pocket.

Private insurance

Coverage varies wildly by plan, insurer, and indication. Some commercial plans cover PGx testing for specific situations (treatment-resistant depression, polypharmacy in elderly patients), while others deny all PGx claims. Prior authorization is usually required. Even when covered, the patient responsibility (copay, coinsurance, deductible) may be substantial.

The practical reality: if your insurance does not cover PGx testing, the self-pay cost of GeneSight ($330) or raw DNA reuse ($19 to $59) makes insurance coverage less of a deciding factor than it might seem.

What about Medicaid?

Medicaid coverage for PGx testing is state-dependent and generally more limited than Medicare. Some states cover it for specific indications; many do not. Check with your state Medicaid program for current coverage details.

The Affordable Alternative: Reusing Existing DNA Data

If you have already taken a consumer DNA test, your raw data file contains pharmacogenomic markers. You have already paid for the genotyping — the pharmacogenomic analysis is an additional layer of interpretation applied to data you own.

DecodeMyBio reports use the same CPIC guidelines and PharmGKB evidence levels as clinical tests. The key differences are cost, access, and the chip-based vs. sequencing-based distinction discussed above. For most common pharmacogenomic decisions, the clinically actionable variants are the same.

This approach is best for people who want actionable pharmacogenomic information without the cost, time, and access barriers of clinical testing. It is not a replacement for clinical-grade sequencing when that level of detail is needed, but for the majority of drug-gene interactions, it provides the same core information at a fraction of the price.

What You Get at Each Price Point

DecodeMyBio offers several report tiers, each covering different pharmacogenomic areas:

• $19 \u2014 Celiac & Gluten Screening: HLA-DQ2/DQ8 screening that rules in or rules out genetic susceptibility to celiac disease. One of the highest-value genetic screening tests available — a clinical HLA typing test costs $100 to $300.
• $29 \u2014 Cannabis & CBD Report: CYP2C9, CYP3A4, CYP2C19 metabolism plus pharmacodynamic variants affecting THC and CBD response. Useful for medical cannabis patients or anyone using CBD products.
• $39 \u2014 Nutrition & Methylation Report: MTHFR, FUT2, VDR, BCMO1, and related genes affecting folate, B12, vitamin D, and other nutrient metabolism pathways. Also $39 for the Pain & Anesthesia Report covering CYP2D6, OPRM1, COMT, and BDNF.
• $49 \u2014 Medication Safety Report: Broad multi-gene panel covering 48+ medications across psychiatry, cardiology, pain, and GI. The widest coverage for drug-gene interactions.
• $59 \u2014 Psychiatric Report: Deep focus on CYP2D6, CYP2C19, CYP3A4, and pharmacodynamic genes relevant to antidepressants, antipsychotics, ADHD medications, benzodiazepines, and mood stabilizers. The most detailed report for mental health medication guidance.

View sample reports for each tier to see exactly what is included.

Cost vs. Value: When to Spend More

The question is not just “how much does it cost?” but “what is the cost of not knowing?”

Consider the math for psychiatric medications: the average patient tries 2 to 3 antidepressants before finding one that works. Each trial takes 4 to 8 weeks, plus tapering time. That is 3 to 9 months of suboptimal treatment, plus the cost of doctor visits, prescriptions, missed work, and reduced quality of life. A $59 psychiatric pharmacogenomic report — or even a $330 GeneSight test — is a small investment compared to months of trial-and-error.

Clinical testing is worth the premium when:

• You need a result that your doctor or institution will accept at face value (some providers prefer CLIA-certified results)
• You have insurance that covers it (especially Medicare)
• You need comprehensive rare variant detection (e.g., CYP2D6 gene deletions or duplications)
• You are making a high-stakes medication decision and want maximum certainty

Raw DNA reuse is sufficient when:

• You want to screen your pharmacogenomic profile before a doctor visit
• You need quick results (minutes vs. weeks)
• You are cost-sensitive and want actionable information at the lowest possible price
• You already have consumer DNA data and want to extract more value from it

Hidden Costs to Watch For

Beyond the testing cost itself, there are potential additional expenses to keep in mind:

• Follow-up appointments: You may need an appointment with your prescriber to discuss PGx results and adjust medications. This is a standard office visit cost. Some clinical PGx services include a pharmacist consultation; most raw DNA reuse services do not.
• Repeat testing: For raw DNA reuse, you pay per report — so if you want both the psychiatric and pain reports, that is $59 + $39 = $98. Clinical tests typically provide one comprehensive result.
• Genetic counseling: If results reveal a concerning finding (particularly HLA variants or unexpected metabolizer status), you may want to consult a genetic counselor. Counseling sessions typically cost $100 to $300 out of pocket if not covered by insurance.
• The DNA test itself: If you do not already have consumer DNA data, add $99 to $199 for a 23andMe or AncestryDNA kit. This is a one-time cost — the raw data can be used for multiple reports.

Already Have DNA Data?

If you have raw data from 23andMe, AncestryDNA, or another consumer DNA test, you can get your first pharmacogenomic report starting from $19. No doctor's order, no insurance authorization, no lab visit — just upload your data and get results in minutes.